Biologics Global Market Briefing 2021: Covid 19 Impact and Recovery

Biologics Global Market Briefing 2021: Covid 19 Impact and Recovery

The global biologics market grew from $167.33 billion in 2015 to $253.4 billion in 2020 at a CAGR of 8.65%. The global biologics market is expected to grow from $253.4 billion in 2020 to $420.57 billion in 2025 at a CAGR of 10.66%.

Biologics Global Market Briefing 2021: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global biologics sector.

Reasons to Purchase

  • Fully updated for 2021 including the impact of the Covid 19/ Novel Coronavirus.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and key trends
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Biologics Global Market Briefing 2021: Covid 19 Impact and Recovery from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the biologics market revenues, covering both the historic growth of the market and forecasting the future.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

The trends and strategies section highlights the likely future developments in the biologics market and suggests approaches.

Scope

Markets Covered: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines

Companies Mentioned: AbbVie; Johnson & Johnson; Amgen; F. Hoffmann-La Roche Ltd.; GlaxosmithKline

Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa

Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa

Time series: Five years historic and forecast

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

AbbVie; Johnson & Johnson; Amgen; F. Hoffmann-La Roche Ltd.; GlaxosmithKline


1. Biologics Market Characteristics
2. Biologics Market Trends And Strategies
2.1. Demand For Biologics In The Treatment Of Complex Diseases
2.2. Development And Increasing Demand For Next Generation Biologics
2.3. Revised FDA Regulations To Facilitate Biologics Drug Development
2.4. Biologics For Dermatology Diseases
2.5. Increase In Mergers And Acquisitions Activity
3. Biologics Market Historic Growth
3.1. Drivers Of The Market
3.2. Restraints On The Market
4. Biologics Market Forecast Growth
4.1. Drivers Of The Market
4.2. Restraints On The Market
5. Biologics Market Segmentation
5.1. Global Biologics Market, Split By Segment, 2020, $ Billion
5.2. Global Biologics Market, Historic And Forecast, Split By Segment, 2015-2025
6. Biologics Market Geography Regional Comparison
6.1. Global Biologics Market, Split By Region, 2020, $ Billion
6.2. Global Biologics Market, Historic And Forecast Growth Rate, Split By Region, 2015-2025
6.3. Asia Pacific Biologics Market Analysis
6.3.1. Asia Pacific Biologics Market, 2015–2025
6.3.2. Asia Pacific Biologics Market, Split By Country, 2020
6.3.3. Asia Pacific Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2015-2025
6.3.4. Asia Pacific Biologics Market, Per Capita Average Expenditure, By Country, 2020, USD($)
6.4. North America Biologics Market Analysis
6.4.1. North America Biologics Market, 2015–2025
6.4.2. North America Biologics Market, Split By Country, 2020
6.4.3. North America Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2015-2025
6.4.4. North America Biologics Market, Per Capita Average Expenditure, By Country, 2020, USD($)
6.5. Western Europe Biologics Market Analysis
6.5.1. Western Europe Biologics Market, 2015–2025
6.5.2. Western Europe Biologics Market, Split By Country, 2020
6.5.3. Western Europe Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2015-2025
6.5.4. Western Europe Biologics Market, Per Capita Average Expenditure, By Country, 2020, USD($)
6.6. Eastern Europe Biologics Market Analysis
6.6.1. Eastern Europe Biologics Market, 2015–2025
6.6.2. Eastern Europe Biologics Market, Split By Country, 2020
6.6.3. Eastern Europe Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2015-2025
6.6.4. Eastern Europe Biologics Market, Per Capita Average Expenditure, By Country, 2020, USD($)
6.7. South America Biologics Market Analysis
6.7.1. South America Biologics Market, 2015–2025
6.7.2. South America Biologics Market, Split By Country, 2020
6.7.3. South America Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2015-2025
6.7.4. South America Biologics Market, Per Capita Average Expenditure, By Country, 2020, USD($)
6.8. Africa Biologics Market Analysis
6.8.1. Africa Biologics Market, 2015–2025
6.8.2. Africa Biologics Market, Split By Country, 2020
6.8.3. Africa Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2015-2025
6.8.4. Africa Biologics Market, Per Capita Average Expenditure, By Country, 2020, USD($)
6.9. Middle East Biologics Market Analysis
6.9.1. Middle East Biologics Market, 2015–2025
6.9.2. Middle East Biologics Market, Split By Country, 2020
6.9.3. Middle East Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2015-2025
6.9.4. Middle East Biologics Market, Per Capita Average Expenditure, By Country, 2020, USD($)
7. Biologics Market Competitive Landscape
7.1. Company Profiles
7.2. AbbVie
7.2.1. Company Overview
7.2.2. AbbVie Offers Products And Services Across Industries
7.2.3. AbbVie Financial Performance
7.3. Johnson & Johnson
7.3.1. Company Overview
7.3.2. J&J Offers Products and Services Across Industries
7.3.3. J&J Financial Performance
7.4. Amgen
7.4.1. Company Overview
7.4.2. Amgen Offers Products And Services Across Industries
7.4.3. Amgen Financial Performance
8. Appendix
8.1. Market Data Sources
8.2. NAICS Definition Of The Industry Covered In This Report
8.3. Research Methodology
8.4. Abbreviations
8.5. Currencies
8.6. Research Inquiries
8.7. The Business Research Company
9. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings